This pipeline uses various statistical tests to identify miRs whose expression levels correlated to selected clinical features.
Testing the association between 544 miRs and 9 clinical features across 158 samples, statistically thresholded by Q value < 0.05, 5 clinical features related to at least one miRs.
-
1 miR correlated to 'Time to Death'.
-
HSA-MIR-549
-
2 miRs correlated to 'AGE'.
-
HSA-MIR-424 , HSA-MIR-1-2
-
11 miRs correlated to 'PATHOLOGY.M.STAGE'.
-
HSA-MIR-202 , HSA-MIR-509-3 , HSA-MIR-509-1 , HSA-MIR-514-1 , HSA-MIR-509-2 , ...
-
30 miRs correlated to 'HISTOLOGICAL.TYPE'.
-
HSA-MIR-944 , HSA-MIR-205 , HSA-MIR-194-2 , HSA-MIR-192 , HSA-MIR-194-1 , ...
-
23 miRs correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
-
HSA-MIR-143 , HSA-MIR-660 , HSA-LET-7F-2 , HSA-MIR-19A , HSA-MIR-20A , ...
-
No miRs correlated to 'PATHOLOGY.T.STAGE', 'PATHOLOGY.N.STAGE', 'NUMBERPACKYEARSSMOKED', and 'NUMBER.OF.LYMPH.NODES'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of miRs that are significantly associated with each clinical feature at Q value < 0.05.
Clinical feature | Statistical test | Significant miRs | Associated with | Associated with | ||
---|---|---|---|---|---|---|
Time to Death | Cox regression test | N=1 | shorter survival | N=1 | longer survival | N=0 |
AGE | Spearman correlation test | N=2 | older | N=1 | younger | N=1 |
PATHOLOGY T STAGE | Spearman correlation test | N=0 | ||||
PATHOLOGY N STAGE | t test | N=0 | ||||
PATHOLOGY M STAGE | ANOVA test | N=11 | ||||
HISTOLOGICAL TYPE | ANOVA test | N=30 | ||||
RADIATIONS RADIATION REGIMENINDICATION | t test | N=23 | yes | N=16 | no | N=7 |
NUMBERPACKYEARSSMOKED | Spearman correlation test | N=0 | ||||
NUMBER OF LYMPH NODES | Spearman correlation test | N=0 |
Table S1. Basic characteristics of clinical feature: 'Time to Death'
Time to Death | Duration (Months) | 0-177 (median=12.7) |
censored | N = 120 | |
death | N = 31 | |
Significant markers | N = 1 | |
associated with shorter survival | 1 | |
associated with longer survival | 0 |
Table S2. Get Full Table List of one miR significantly associated with 'Time to Death' by Cox regression test
HazardRatio | Wald_P | Q | C_index | |
---|---|---|---|---|
HSA-MIR-549 | 2.3 | 6.472e-05 | 0.035 | 0.783 |
Figure S1. Get High-res Image As an example, this figure shows the association of HSA-MIR-549 to 'Time to Death'. four curves present the cumulative survival rates of 4 quartile subsets of patients. P value = 6.47e-05 with univariate Cox regression analysis using continuous log-2 expression values.

Table S3. Basic characteristics of clinical feature: 'AGE'
AGE | Mean (SD) | 47.64 (13) |
Significant markers | N = 2 | |
pos. correlated | 1 | |
neg. correlated | 1 |
Table S4. Get Full Table List of 2 miRs significantly correlated to 'AGE' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
HSA-MIR-424 | -0.326 | 3.097e-05 | 0.0168 |
HSA-MIR-1-2 | 0.3141 | 6.537e-05 | 0.0355 |
Figure S2. Get High-res Image As an example, this figure shows the association of HSA-MIR-424 to 'AGE'. P value = 3.1e-05 with Spearman correlation analysis. The straight line presents the best linear regression.

Table S5. Basic characteristics of clinical feature: 'PATHOLOGY.T.STAGE'
PATHOLOGY.T.STAGE | Mean (SD) | 1.34 (0.6) |
N | ||
1 | 86 | |
2 | 31 | |
3 | 2 | |
4 | 2 | |
Significant markers | N = 0 |
Table S6. Basic characteristics of clinical feature: 'PATHOLOGY.N.STAGE'
PATHOLOGY.N.STAGE | Labels | N |
class0 | 78 | |
class1 | 39 | |
Significant markers | N = 0 |
Table S7. Basic characteristics of clinical feature: 'PATHOLOGY.M.STAGE'
PATHOLOGY.M.STAGE | Labels | N |
M0 | 68 | |
M1 | 3 | |
MX | 54 | |
Significant markers | N = 11 |
Table S8. Get Full Table List of top 10 miRs differentially expressed by 'PATHOLOGY.M.STAGE'
ANOVA_P | Q | |
---|---|---|
HSA-MIR-202 | 1.014e-07 | 5.51e-05 |
HSA-MIR-509-3 | 2.558e-07 | 0.000139 |
HSA-MIR-509-1 | 3.608e-07 | 0.000196 |
HSA-MIR-514-1 | 6.149e-07 | 0.000333 |
HSA-MIR-509-2 | 9.271e-07 | 0.000501 |
HSA-MIR-514-2 | 1.091e-06 | 0.000588 |
HSA-MIR-514-3 | 1.838e-06 | 0.000989 |
HSA-MIR-449A | 1.306e-05 | 0.00701 |
HSA-MIR-345 | 3.585e-05 | 0.0192 |
HSA-MIR-190B | 3.603e-05 | 0.0193 |
Figure S3. Get High-res Image As an example, this figure shows the association of HSA-MIR-202 to 'PATHOLOGY.M.STAGE'. P value = 1.01e-07 with ANOVA analysis.

Table S9. Basic characteristics of clinical feature: 'HISTOLOGICAL.TYPE'
HISTOLOGICAL.TYPE | Labels | N |
ADENOSQUAMOUS | 2 | |
CERVICAL SQUAMOUS CELL CARCINOMA | 132 | |
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | 4 | |
ENDOCERVICAL TYPE OF ADENOCARCINOMA | 16 | |
ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | 1 | |
MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE | 3 | |
Significant markers | N = 30 |
Table S10. Get Full Table List of top 10 miRs differentially expressed by 'HISTOLOGICAL.TYPE'
ANOVA_P | Q | |
---|---|---|
HSA-MIR-944 | 2.701e-34 | 1.47e-31 |
HSA-MIR-205 | 2.586e-29 | 1.4e-26 |
HSA-MIR-194-2 | 1.016e-19 | 5.51e-17 |
HSA-MIR-192 | 1.15e-19 | 6.22e-17 |
HSA-MIR-194-1 | 1.996e-18 | 1.08e-15 |
HSA-MIR-375 | 3.56e-15 | 1.92e-12 |
HSA-MIR-203 | 7.83e-13 | 4.21e-10 |
HSA-MIR-215 | 1.227e-10 | 6.59e-08 |
HSA-MIR-10A | 5.567e-10 | 2.98e-07 |
HSA-MIR-1293 | 1.102e-08 | 5.9e-06 |
Figure S4. Get High-res Image As an example, this figure shows the association of HSA-MIR-944 to 'HISTOLOGICAL.TYPE'. P value = 2.7e-34 with ANOVA analysis.

23 miRs related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
Table S11. Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'
RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
NO | 30 | |
YES | 128 | |
Significant markers | N = 23 | |
Higher in YES | 16 | |
Higher in NO | 7 |
Table S12. Get Full Table List of top 10 miRs differentially expressed by 'RADIATIONS.RADIATION.REGIMENINDICATION'
T(pos if higher in 'YES') | ttestP | Q | AUC | |
---|---|---|---|---|
HSA-MIR-143 | -7.04 | 1.861e-09 | 1.01e-06 | 0.8151 |
HSA-MIR-660 | 6.77 | 3.066e-08 | 1.66e-05 | 0.8365 |
HSA-LET-7F-2 | -6.27 | 4.558e-08 | 2.46e-05 | 0.788 |
HSA-MIR-19A | 6.16 | 1.458e-07 | 7.86e-05 | 0.7995 |
HSA-MIR-20A | 6 | 3.373e-07 | 0.000181 | 0.8083 |
HSA-MIR-338 | 5.65 | 6.463e-07 | 0.000347 | 0.7911 |
HSA-MIR-93 | 5.73 | 6.933e-07 | 0.000372 | 0.788 |
HSA-MIR-15A | 5.65 | 8.587e-07 | 0.000459 | 0.807 |
HSA-MIR-19B-2 | 5.5 | 1.223e-06 | 0.000653 | 0.7831 |
HSA-MIR-374A | -5.31 | 2.505e-06 | 0.00134 | 0.7703 |
Figure S5. Get High-res Image As an example, this figure shows the association of HSA-MIR-143 to 'RADIATIONS.RADIATION.REGIMENINDICATION'. P value = 1.86e-09 with T-test analysis.

Table S13. Basic characteristics of clinical feature: 'NUMBERPACKYEARSSMOKED'
NUMBERPACKYEARSSMOKED | Mean (SD) | 18.18 (12) |
Significant markers | N = 0 |
-
Expresson data file = CESC-TP.miRseq_RPKM_log2.txt
-
Clinical data file = CESC-TP.merged_data.txt
-
Number of patients = 158
-
Number of miRs = 544
-
Number of clinical features = 9
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.